122 related articles for article (PubMed ID: 32250004)
1. pH-Responsive Polymers for Improving the Signal-to-Noise Ratio of Hypoxia PET Imaging with [
Goos JACM; Davydova M; Lengkeek N; Greguric I; Whittaker MR; Quinn JF; Baell JB; Lewis JS; Davis TP
Macromol Rapid Commun; 2020 Jun; 41(11):e2000061. PubMed ID: 32250004
[TBL] [Abstract][Full Text] [Related]
2.
Yu W; Qiao F; Su X; Zhang D; Wang H; Jiang J; Xu H
Biomed Pharmacother; 2019 Nov; 119():109454. PubMed ID: 31526971
[TBL] [Abstract][Full Text] [Related]
3. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of [
Nakata N; Kiriu M; Okumura Y; Zhao S; Nishijima KI; Shiga T; Tamaki N; Kuge Y; Matsumoto H
Nucl Med Biol; 2019 Mar; 70():39-45. PubMed ID: 30836255
[TBL] [Abstract][Full Text] [Related]
5. Introducing fluorine-18 fluoromisonidazole positron emission tomography for the localisation and quantification of pig liver hypoxia.
Piert M; Machulla H; Becker G; Stahlschmidt A; Patt M; Aldinger P; Dissmann PD; Fischer H; Bares R; Becker HD; Lauchart W
Eur J Nucl Med; 1999 Feb; 26(2):95-109. PubMed ID: 9933343
[TBL] [Abstract][Full Text] [Related]
6. The cellular basis of increased PET hypoxia tracer uptake in focal cerebral ischemia with comparison between [
Little PV; Arnberg F; Jussing E; Lu L; Ingemann Jensen A; Mitsios N; Mulder J; Tran TA; Holmin S
J Cereb Blood Flow Metab; 2021 Mar; 41(3):617-629. PubMed ID: 32423333
[TBL] [Abstract][Full Text] [Related]
7. Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [
Kelada OJ; Rockwell S; Zheng MQ; Huang Y; Liu Y; Booth CJ; Decker RH; Oelfke U; Carson RE; Carlson DJ
Mol Imaging Biol; 2017 Dec; 19(6):893-902. PubMed ID: 28409339
[TBL] [Abstract][Full Text] [Related]
8. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.
Lee NY; Mechalakos JG; Nehmeh S; Lin Z; Squire OD; Cai S; Chan K; Zanzonico PB; Greco C; Ling CC; Humm JL; Schöder H
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):2-13. PubMed ID: 17869020
[TBL] [Abstract][Full Text] [Related]
9. Rapid and simplified synthesis of [
Fernandez-Maza L; Egea-Guerrero JJ; Balcerzyk M; Civantos-Jubera G; Gordillo-Escobar E; Vilches-Arenas A; Fernandez-Gomez I; Parrado-Gallego A; Murillo-Cabezas F
Appl Radiat Isot; 2018 Feb; 132():79-84. PubMed ID: 29172058
[TBL] [Abstract][Full Text] [Related]
10. Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of
Okamoto M; Yamaguchi S; Sawaya R; Echizenya S; Ishi Y; Kaneko S; Motegi H; Toyonaga T; Hirata K; Fujimura M
Biomed Res Int; 2024; 2024():2973407. PubMed ID: 38449509
[TBL] [Abstract][Full Text] [Related]
11. A Comparative Study of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole PET/CT in Patients with Lung Cancer.
Wei Y; Zhao W; Huang Y; Yu Q; Zhu S; Wang S; Zhao S; Hu X; Yu J; Yuan S
PLoS One; 2016; 11(6):e0157606. PubMed ID: 27322586
[TBL] [Abstract][Full Text] [Related]
12. Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET.
Bejot R; Kersemans V; Kelly C; Carroll L; King RC; Gouverneur V; Elizarov AM; Ball C; Zhang J; Miraghaie R; Kolb HC; Smart S; Hill S
Nucl Med Biol; 2010 Jul; 37(5):565-75. PubMed ID: 20610161
[TBL] [Abstract][Full Text] [Related]
13. Correlation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images.
Mönnich D; Troost EG; Kaanders JH; Oyen WJ; Alber M; Zips D; Thorwarth D
Acta Oncol; 2013 Oct; 52(7):1308-13. PubMed ID: 23984808
[TBL] [Abstract][Full Text] [Related]
14. NanoPET imaging of [(18)F]fluoromisonidazole uptake in experimental mouse tumours.
Wyss MT; Honer M; Schubiger PA; Ametamey SM
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):311-8. PubMed ID: 16258762
[TBL] [Abstract][Full Text] [Related]
15. Modelling and simulation of the influence of acute and chronic hypoxia on [18F]fluoromisonidazole PET imaging.
Mönnich D; Troost EG; Kaanders JH; Oyen WJ; Alber M; Thorwarth D
Phys Med Biol; 2012 Mar; 57(6):1675-84. PubMed ID: 22398239
[TBL] [Abstract][Full Text] [Related]
16. 18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinoma.
Sato J; Kitagawa Y; Yamazaki Y; Hata H; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N
J Nucl Med; 2013 Jul; 54(7):1060-5. PubMed ID: 23699668
[TBL] [Abstract][Full Text] [Related]
17. Reduction of [(18)F]fluoromisonidazole uptake after neoadjuvant chemotherapy for head and neck squamous cell carcinoma.
Yamane T; Kikuchi M; Shinohara S; Senda M
Mol Imaging Biol; 2011 Apr; 13(2):227-31. PubMed ID: 20552284
[TBL] [Abstract][Full Text] [Related]
18. A (99m)Tc-labeled misonidazole analogue: step toward a (99m)Tc-alternative to [18F]fluromisonidazole for detecting tumor hypoxia.
Mallia MB; Mathur A; Sarma HD; Banerjee S
Cancer Biother Radiopharm; 2015 Mar; 30(2):79-86. PubMed ID: 25569675
[TBL] [Abstract][Full Text] [Related]
19. Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia.
Yang DJ; Wallace S; Cherif A; Li C; Gretzer MB; Kim EE; Podoloff DA
Radiology; 1995 Mar; 194(3):795-800. PubMed ID: 7862981
[TBL] [Abstract][Full Text] [Related]
20. Quantitative [
Sorace AG; Syed AK; Barnes SL; Quarles CC; Sanchez V; Kang H; Yankeelov TE
Mol Imaging Biol; 2017 Feb; 19(1):130-137. PubMed ID: 27506906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
